{"id":19802,"date":"2025-07-08T13:15:38","date_gmt":"2025-07-08T11:15:38","guid":{"rendered":"https:\/\/adragos-pharma.com\/?p=19802"},"modified":"2025-07-14T13:19:45","modified_gmt":"2025-07-14T11:19:45","slug":"autologous-vs-allogeneic-tailoring-biologic-manufacturing","status":"publish","type":"post","link":"https:\/\/adragos-pharma.com\/autologous-vs-allogeneic-tailoring-biologic-manufacturing\/","title":{"rendered":"Autologous vs Allogeneic: Tailoring Biologic Manufacturing"},"content":{"rendered":"\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>Table of Contents<\/h2><nav><div><div><a href=\"#understanding-the-terms-autologous-and-allogeneic-defined\">Decoding the Basics: What Are Autologous and Allogeneic Approaches?<\/a><\/div><div><a href=\"#common-therapeutic-uses\">Common Therapeutic Uses of Autologous and Allogeneic <\/a><div><div><a href=\"#biologics-plasma-therapies\">Biologics &amp; Plasma Therapies<\/a><\/div><div><a href=\"#tissue-engineering-and-implants\">Tissue Engineering and Implants<\/a><\/div><div><a href=\"#next-generation-vaccines-and-personalized-medicine\">Next-Generation Vaccines and Personalized Medicine<\/a><\/div><\/div><\/div><div><a href=\"#advantages-and-disadvantages-autologous-vs-allogeneic\">Advantages and Disadvantages: Autologous vs Allogeneic<\/a><div><div><a href=\"#autologous-approaches\">Autologous Approaches<\/a><\/div><div><a href=\"#allogeneic-approaches\">Allogeneic Approaches<\/a><\/div><\/div><\/div><div><a href=\"#clinical-process-flow-bone-marrow-and-stem-cell-transplants\">A Partner for Flexible and High-Quality Manufacturing<\/a><\/div><div><a href=\"#fa-qs-autologous-vs-allogeneic\">FAQs: Autologous vs Allogeneic<\/a><div><\/div><\/div><\/div><\/nav><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">In advanced medicine, the distinction between <strong>autologous<\/strong> and <strong>allogeneic<\/strong> sources is foundational\u2014not just in clinical care, but throughout <strong>drug development<\/strong> and <strong>pharmaceutical manufacturing<\/strong>. While most commonly referenced in cell and gene therapy, these concepts impact a broad array of biologic products, blood-based medicines, and tissue-derived therapies. For <strong>contract development and manufacturing organizations (CDMOs)<\/strong> such as Adragos Pharma, understanding these terms is critical to supporting client innovations from <strong>bench to patient<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"understanding-the-terms-autologous-and-allogeneic-defined\"><strong><strong>Decoding the Basics: What Are Autologous and Allogeneic Approaches?<\/strong><\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Simply put, <strong>autologous<\/strong> means <strong>\u201cfrom yourself\u2014back to yourself.\u201d<\/strong> When a treatment uses cells, tissues, or biological materials collected from a patient and then gives them back after processing, that process is called autologous. This option offers a high level of <strong>personalization<\/strong> and is typically less likely to trigger the body\u2019s defense systems.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">On the other hand, <strong>allogeneic<\/strong> means <strong>\u201cfrom a donor to a recipient.\u201d<\/strong> Here, materials come from another person (often carefully matched and screened). This approach is fundamental for creating <strong>standardized, \u201coff-the-shelf\u201d therapies<\/strong> that can serve many patients with a single batch.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Both meet unique and rapidly growing needs in pharmaceutical development\u2014but they also come with their own set of challenges.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/07\/autologous-vs-allogeneic-1.png\" alt=\"image showing the differences between autologous and allogeneic cell therapies\" class=\"wp-image-20232\" srcset=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/07\/autologous-vs-allogeneic-1.png 1024w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/07\/autologous-vs-allogeneic-1-300x225.png 300w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/07\/autologous-vs-allogeneic-1-768x576.png 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"common-therapeutic-uses\"><strong>Common Therapeutic Uses<\/strong> of A<strong><strong>utologous and Allogeneic <\/strong><\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"biologics-plasma-therapies\"><strong>Biologics &amp; Plasma Therapies<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Autologous Examples:<\/strong>&nbsp;Think of niche treatments like platelet-rich plasma (PRP) therapy, where a patient\u2019s own blood is processed and returned for wound healing or joint regeneration.<\/li>\n\n\n\n<li><strong>Allogeneic Examples:<\/strong>&nbsp;Most blood plasma products on the market\u2014like immunoglobulins or clotting factors\u2014are pooled from several healthy donors, purified, and delivered to patients in need worldwide.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"tissue-engineering-and-implants\"><strong>Tissue Engineering and Implants<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Autologous Grafts:<\/strong>&nbsp;Here, a patient may have a piece of bone, skin, or tendon removed, treated, and re-implanted in another part of their body. This approach significantly reduces the risk of rejection or complications.<\/li>\n\n\n\n<li><strong>Allogeneic Grafts:<\/strong>&nbsp;Alternatively, donor tissue (skin, bone, valves) from tissue banks is standardized and used in reconstructive surgeries, trauma care, or transplants for patients lacking healthy autologous material.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"next-generation-vaccines-and-personalized-medicine\"><strong>Next-Generation Vaccines and Personalized Medicine<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Autologous Vaccines:<\/strong>&nbsp;The future holds vaccines made from a patient\u2019s own tumor antigens, potentially leading to hyper-targeted cancer therapies.<\/li>\n\n\n\n<li><strong>Allogeneic Vaccines:<\/strong>&nbsp;Everyday flu shots or COVID-19 vaccines are allogeneic\u2014engineered for the masses, with broad spectrum effectiveness.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"advantages-and-disadvantages-autologous-vs-allogeneic\"><strong>Advantages and Disadvantages: Autologous vs Allogeneic<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"autologous-approaches\"><strong>Autologous Approaches<\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"advantages\"><strong>Advantages:<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Unmatched compatibility:<\/strong>&nbsp;Since it\u2019s your own material, risk of immune rejection or&nbsp;<strong>graft-versus-host disease<\/strong>&nbsp;is minimal.<\/li>\n\n\n\n<li><strong>No long wait times:<\/strong>&nbsp;No need to search for a matching donor\u2014everything starts with you.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"disadvantages\"><strong>Disadvantages:<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Personalized means complex:<\/strong>&nbsp;Every treatment batch is unique to each patient, requiring meticulous tracking and customization.<\/li>\n\n\n\n<li><strong>Time &amp; scalability constraints:<\/strong>&nbsp;This process can be slower and may not be ideal for large urgent patient populations.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"allogeneic-approaches\"><strong>Allogeneic Approaches<\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"advantages-1\"><strong>Advantages:<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Wider access:<\/strong>&nbsp;One donor\u2019s contribution can help dozens (or hundreds) of recipients.<\/li>\n\n\n\n<li><strong>Faster response:<\/strong>&nbsp;Standardized batches mean therapies can be made in advance and ready as soon as they\u2019re needed.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"disadvantages-2\"><strong>Disadvantages:<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Immune risks present:<\/strong>&nbsp;Even with careful matching, there\u2019s still a potential for immune response or rejection.<\/li>\n\n\n\n<li><strong>Safety and screening:<\/strong>&nbsp;Rigorous donor screening and regulatory controls are always essential.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"clinical-process-flow-bone-marrow-and-stem-cell-transplants\"><strong>A Partner for Flexible and High-Quality Manufacturing<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Whether a pharmaceutical program relies on <strong>autologous<\/strong> or <strong>allogeneic<\/strong> principles, the path from development to delivery requires adaptable, high-quality manufacturing. For projects demanding agility\u2014such as small-batch, patient-specific runs\u2014or those requiring the highest compliance for broader-scale, standardized production, robust expertise and advanced infrastructure are essential.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With over <strong>20 years of experience<\/strong>, <strong>Adragos Pharma\u2019s Swiss Jura facility<\/strong> offers comprehensive support tailored to both clinical and commercial manufacturing. Specializing in the aseptic production of lyophilized and liquid sterile (bio)pharmaceutical products through fill and finish, the facility is ideally suited for <strong>small clinical and commercial batches<\/strong>. Certified by both <strong>GMP and FDA<\/strong>, Jura upholds the highest quality and safety standards.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Clients benefit from end-to-end solutions:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Scale-up and Technology Transfer:<\/strong>&nbsp;Seamless transition from development to production, backed by strong technical expertise.<\/li>\n\n\n\n<li><strong>Flexible Batch Production:<\/strong>&nbsp;No minimum batch sizes\u2014ensuring the ultimate flexibility for unique, complex, or limited-quantity projects.<\/li>\n\n\n\n<li><strong>Aseptic Process Simulation (APS):<\/strong>&nbsp;Fully compliant APS services reinforce product sterility and efficacy.<\/li>\n\n\n\n<li><strong>GMP &amp; FDA Regulatory Support:<\/strong>&nbsp;Comprehensive compliance guidance, making even the most complex clinical projects manageable.<\/li>\n\n\n\n<li><strong>API Management and Specialized Formulations:<\/strong>&nbsp;Skilled handling of sensitive or valuable materials, including peptides, biologicals, controlled substances, and ophthalmic products.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">From <strong>pilot and scale-up batches<\/strong> for preclinical and early-phase clinical studies to full <strong>clinical or commercial manufacturing<\/strong>, release analytics, packaging, stability studies, and GMP storage, Adragos Jura delivers Swiss precision and reliability every step of the way.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">By integrating technology, technical know-how, and proactive project management, the facility empowers clients to confidently advance their products\u2014whether highly-personalized (autologous) or broadly-distributed (allogeneic)\u2014from early development through to market launch.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In conclusion, the division between <strong>autologous<\/strong> and <strong>allogeneic<\/strong> is about much more than biology\u2014it shapes every stage of the pharmaceutical journey, from <strong>research and regulatory planning<\/strong> to <strong>manufacturing and logistics<\/strong>. As the world moves toward more <strong>personalized and precise therapies<\/strong>, making an informed choice is essential for patients and developers alike.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>At Adragos Pharma, we help our partners navigate these complexities, ensuring every product\u2014whether made for one or many\u2014meets the highest standards of safety, efficacy, and quality.<\/strong><\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-fe48e5de wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-secondary-background-color has-background wp-element-button\" href=\"https:\/\/adragos-pharma.com\/contact-us\/?utm_campaign=Banner_Blog_Articles&amp;utm_source=blog&amp;utm_medium=organic_search\">Do you want to know more about us?<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:44px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"fa-qs-autologous-vs-allogeneic\"><strong>FAQs: Autologous vs Allogeneic<\/strong><\/h2>\n\n\n\n<div class=\"wp-block-gutena-accordion gutena-accordion-block gutena-accordion-block-98375b-e4 is-layout-flow wp-block-gutena-accordion-is-layout-flow\" data-single=\"true\">\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"whats-the-difference-between-autologous-and-allogeneic\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong>What\u2019s the difference between autologous and allogeneic?<\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\"><strong>Autologous<\/strong> utilizes the patient\u2019s own <strong>cells<\/strong>, minimizing rejection risk; <strong>allogeneic<\/strong> uses genetically matched <strong>donor<\/strong> <strong>cells<\/strong>, requiring tissue compatibility and often delivering immune-mediated therapeutic benefits.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"what-is-the-difference-between-autologous-and-allogeneic-transfusions\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong>What is the difference between autologous and allogeneic transfusions?<\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\"><strong>Autologous transfusion<\/strong> involves a patient\u2019s own <strong>blood<\/strong> collected ahead of time. <strong>Allogeneic transfusion<\/strong> uses <strong>blood<\/strong> from another person and is subject to immune matching protocols.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"what-is-an-example-of-allogeneic\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong><strong>What is an example of allogeneic?<\/strong><\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">A <strong>bone marrow transplant<\/strong> from an unrelated <strong>donor<\/strong> for treatment of relapsed leukemia.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"what-is-the-purpose-of-autologous\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong><strong>What is the purpose of autologous?<\/strong><\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">To enable safe transplantation and <strong>cell therapies<\/strong> without the risk of immune-mediated rejection or <strong>graft versus host disease<\/strong>.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"is-car-t-allogeneic-or-autologous\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong><strong>Is CAR-T allogeneic or autologous?<\/strong><\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">Most current <strong>CAR-T cell<\/strong> therapies are <strong>autologous<\/strong>, using the patient\u2019s own <strong>immune cells<\/strong>. Next-generation products are exploring <strong>allogeneic CAR-T<\/strong> using healthy <strong>donor<\/strong> sources.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"what-is-meant-by-allogeneic\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong><strong><strong>What is meant by allogeneic?<\/strong><\/strong><\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">A biological product or tissue derived from a genetically different individual of the same species.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"what-is-an-autologous-transplant\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong><strong>What is an autologous transplant?<\/strong><\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">A therapeutic procedure in which a patient receives an infusion of their previously harvested and stored <strong>bone marrow<\/strong>, <strong>blood stem cells<\/strong>, or <strong>blood<\/strong> after high-dose therapy.<\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>In advanced medicine, the distinction between autologous and allogeneic sources is foundational\u2014not just in clinical care, but throughout drug development and pharmaceutical manufacturing. While most commonly referenced in cell and gene therapy, these concepts impact a broad array of biologic [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":16434,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[13],"tags":[],"topics":[287],"locations":[274],"experts":[],"class_list":["post-19802","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","topics-clinical-manufacturing","locations-jura"],"_links":{"self":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/19802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/comments?post=19802"}],"version-history":[{"count":12,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/19802\/revisions"}],"predecessor-version":[{"id":20565,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/19802\/revisions\/20565"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media\/16434"}],"wp:attachment":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media?parent=19802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/categories?post=19802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/tags?post=19802"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/topics?post=19802"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/locations?post=19802"},{"taxonomy":"experts","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/experts?post=19802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}